AI-generated summary
The authors conducted a systematic review and meta-analysis of ten studies, all from China, on repeated low-level red light therapy in children aged 6 to 16 with myopia. They report that children receiving the therapy alongside standard management showed slower myopia progression than controls, with most studies lasting about one year. The authors describe the findings as suggesting a possible adjunctive treatment.
- Studies included
- 10
- Who or what was studied
- Children aged 6 to 16 years with myopia, all studies conducted in China
- Limits stated in the abstract
- Most included studies followed children for only about one year, and the abstract reports results from studies conducted in a single country.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objectives
As Repeated Low-Level Red Light (RLRL) therapy is becoming increasingly prevalent in clinical practice, mainly in the Far East, largely due to its child-friendly nature and the feasibility of home use, this study aims to conduct a systematic review and meta-analysis to evaluate the efficacy of RLRL therapy in managing childhood myopia, specifically in relation to axial length (AL) and spherical equivalent refraction (SER), across a larger group of children aged from 6 to 16 years.
Methods
A systematic literature search was performed using PubMed, Scopus, and Web of Science to access relevant databases and to locate outcome studies. Eligibility criteria included publication type, participant characteristics, and outcomes report. As appropriate, data analysis was conducted using either a random or fixed effects model.
Results
Ten articles were included in the final analysis. All the studies included in the analysis were conducted in China and most of them is shortened to one year follow-up time. The mean difference in change of AL between the study and control groups was -0.33 mm with confidence levels ranging from -0.42 to -0.25 mm. The mean difference in change of SER between the study and control groups was 0.63 D with confidence levels ranging from 0.42 to 0.85 D, which was found to be statistically significant (p < 0.001). The mean difference in AL change at t = 6 months for the RLRL and SVS groups was 0.00 mm (95% CI: -0.10 to 0.10 mm) and 0.23 mm (95% CI: 0.15 to 0.32 mm) respectively. At t = 12 months mean difference in AL change for the RLRL and SVS groups was -0.01 mm (95% CI: -0.16 to 0.13 mm) and 0.35 mm (95% CI: 0.20 to 0.50 mm) respectively. The mean difference in SER change at t = 6 months for the RLRL and SVS groups was 0.18 D (95%CI: -0.03 to 0.39 D) and -0.48 D (95% CI: -0.69 to -0.27 D, respectively. At t = 12 months the mean difference in SER change for RLRL and SVS groups was 0.05 (95% CI -0.31 to 0.42 D), and -0.73 D (95% CI: -1.08 to -0.37 D), respectively.
Conclusions
The results of the meta-analysis indicate that myopic children who received RLRL therapy in addition to standard myopia management demonstrated a slower progression of myopia compared to the control group. These findings suggest that RLRL therapy may be an effective novel adjunctive treatment for myopia controls.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Meta-analysis, Systematic review, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.